Keurig Dr Pepper (NASDAQ:KDP) Downgraded to “Underperform” Rating by BNP Paribas Exane

Keurig Dr Pepper (NASDAQ:KDPGet Free Report) was downgraded by investment analysts at BNP Paribas Exane from a “neutral” rating to an “underperform” rating in a report released on Monday, Marketbeat reports.

A number of other research analysts have also recently weighed in on KDP. Hsbc Global Res cut Keurig Dr Pepper from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 26th. HSBC restated a “hold” rating and issued a $30.00 price target (down previously from $42.00) on shares of Keurig Dr Pepper in a research report on Tuesday, August 26th. Jefferies Financial Group set a $41.00 price target on Keurig Dr Pepper in a research report on Monday, August 25th. Piper Sandler dropped their price target on Keurig Dr Pepper from $40.00 to $35.00 and set an “overweight” rating for the company in a research report on Wednesday, September 17th. Finally, Citigroup dropped their price target on Keurig Dr Pepper from $41.00 to $37.00 and set a “buy” rating for the company in a research report on Tuesday, September 16th. Ten investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Keurig Dr Pepper currently has a consensus rating of “Moderate Buy” and an average price target of $36.77.

Read Our Latest Analysis on KDP

Keurig Dr Pepper Trading Down 0.9%

NASDAQ:KDP opened at $26.25 on Monday. The stock has a fifty day moving average price of $31.27 and a two-hundred day moving average price of $32.89. The stock has a market capitalization of $35.66 billion, a price-to-earnings ratio of 23.44, a PEG ratio of 1.45 and a beta of 0.47. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64. Keurig Dr Pepper has a 1 year low of $25.92 and a 1 year high of $37.91.

Keurig Dr Pepper (NASDAQ:KDPGet Free Report) last released its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.49. The firm had revenue of $4.16 billion during the quarter, compared to analysts’ expectations of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.Keurig Dr Pepper’s revenue was up 6.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.45 earnings per share. As a group, sell-side analysts anticipate that Keurig Dr Pepper will post 1.92 earnings per share for the current fiscal year.

Insider Transactions at Keurig Dr Pepper

In other news, Director Robert James Gamgort sold 208,000 shares of the firm’s stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the transaction, the director directly owned 2,292,169 shares in the company, valued at $75,412,360.10. This trade represents a 8.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the firm’s stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the transaction, the insider owned 82,511 shares in the company, valued at approximately $2,777,320.26. This trade represents a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 447,601 shares of company stock worth $14,825,192. Company insiders own 0.40% of the company’s stock.

Hedge Funds Weigh In On Keurig Dr Pepper

Large investors have recently modified their holdings of the company. Amundi raised its holdings in shares of Keurig Dr Pepper by 7.7% in the 1st quarter. Amundi now owns 4,404,145 shares of the company’s stock worth $156,920,000 after purchasing an additional 315,290 shares during the period. Dynamic Technology Lab Private Ltd raised its holdings in shares of Keurig Dr Pepper by 61.8% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 60,630 shares of the company’s stock valued at $2,075,000 after buying an additional 23,167 shares during the period. China Universal Asset Management Co. Ltd. raised its holdings in shares of Keurig Dr Pepper by 51.8% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 33,510 shares of the company’s stock valued at $1,154,000 after buying an additional 11,435 shares during the period. Praxis Investment Management Inc. raised its holdings in shares of Keurig Dr Pepper by 112.2% during the 1st quarter. Praxis Investment Management Inc. now owns 19,630 shares of the company’s stock valued at $672,000 after buying an additional 10,380 shares during the period. Finally, Vident Advisory LLC raised its holdings in shares of Keurig Dr Pepper by 85.1% during the 1st quarter. Vident Advisory LLC now owns 26,641 shares of the company’s stock valued at $912,000 after buying an additional 12,250 shares during the period. 93.99% of the stock is currently owned by hedge funds and other institutional investors.

Keurig Dr Pepper Company Profile

(Get Free Report)

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

Read More

Analyst Recommendations for Keurig Dr Pepper (NASDAQ:KDP)

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.